The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Consolidated Financial Statements and supplementary data referred to in this Item 7 of this Form 10-K.

This discussion contains forward-looking statements that involve risks and uncertainties. Such statements, which include statements concerning future revenue sources and concentration, selling, general and administrative expenses, research and development expenses, capital resources, additional financings and additional losses, are subject to risks and uncertainties, including, but not limited to, those discussed above in Item 1 and elsewhere in this Form 10-K, particularly in "Risk Factors," that could cause actual results to differ materially from those projected. Unless otherwise expressly indicated, the information set forth in this Form 10-K is as of December 31, 2021, and we undertake no duty to update this information.









  23






                                    Overview


The Company has not generated significant revenues since its inception in February 1998. We continue to devote the bulk of our efforts to the promotion, design, testing and the commercial manufacturing and operations of our crude oil pipeline products in the upstream and midstream energy sector. We anticipate that these efforts will continue during 2022.

Our expenses to date have been funded primarily through the sale of shares of common stock and convertible debt, as well as proceeds from the exercise of stock purchase warrants and options. We raised capital in 2021 and also need to raise substantial additional capital in 2021, and possibly beyond, to fund our sales and marketing efforts, continuing research and development, and certain other expenses, until our revenue base grows sufficiently.

QS Energy operations have been minimally impacted by COVID-19; however, COVID-19 has had a significant negative financial impact across a wide spectrum of industries, both in terms of operations and access to operating capital. The Company's ability to continue operations is, in part, dependent on our access to funding. A published by the National Association of Manufacturers in March 2020 reports that due to COVID-19, 35% of manufacturers surveyed anticipate supply chain disruptions, 53% anticipate changes to operations, and 78% anticipate a negative financial impact. With these facts in mind, no assurances can be made that COVID-19 will not materially affect operations or negatively impact our ability to fund continued operations.





                              Results of Operation



                                QS ENERGY, INC.

                     CONSOLIDATED STATEMENTS OF OPERATIONS



                                                              Year ended
                                        12/31/2021
                                              2021             2020         Change       % Change
Revenues                              $          -     $          -     $        -              -

Operating expenses                         837,000        1,468,000       (631,000 )         (43% )

Research and development expenses 350,000 355,000 (5,000 ) (1% ) Loss from operations

                    (1,187,000 )     (1,823,000 )     (636,000 )         (35% )

Interest and financing expense            (233,000 )       (592,000 )     (359,000 )         (61% )
Net Loss                              $ (1,420,000 )   $ (2,415,000 )   $ (995,000 )         (41% )



Revenue Comparison, 2021 and 2020

The Company recognized no revenues during the twelve-month periods ended December 31, 2020 and December 31, 2021.

Operating Expense Comparison, 2021 and 2020

Operating expenses were $837,000 for the fiscal year ended December 31, 2021, compared to $1,468,000 for the fiscal year ended December 31, 2020, a decrease of $631,000. This decrease was attributable to a decreases in non-cash expenses of $272,000 and in cash expenses of $359,000. Specifically, the decrease in non-cash expenses is attributable to a decrease in stock-based compensation related to directors and employees of $310,000, offset by an increase in stock-based compensation related to consultants of $38,000. The decrease in cash expenses is attributable to decreases in salaries and benefits of $302,000, insurance of $86,000, legal and accounting fees of $39,000, public and investor relations of $28,000, corporate expenses of $8,000, market expenses of $6,000, mail and freight of $4,000, and travel expenses of $3,000, offset by increases in office expenses of $35,000, consulting fees of $32,000, rent of $25,000, computer expenses of $12,000, auto expenses of $5,000, patent maintenance expenses of $5,000, meals and entertainment of $2,000, and other expenses of $1,000.

Research and development expenses were $350,000 for the fiscal year ended December 31, 2021, compared to $355,000 for the fiscal year ended December 31, 2020, a decrease of $5,000. This decrease is attributable to AOT prototype and demonstration project development costs.









  24





Interest expenses were $233,000 for the fiscal year ended December 31, 2021, compared to $592,000 for the fiscal year ended December 31, 2020, a decrease of $359,000. This decrease is attributable to a decrease in interest and financing expense of $96,000 to account the relative fair value of the warrants issued with our convertible notes and the notes' beneficial conversion feature that were recorded as note discounts.

We had a net loss of $1,420,000 or $0.00 loss per share for the fiscal year ended December 31, 2021 compared to a net loss of $2,415,000 or $0.01 loss per share for the fiscal year ended December 31, 2020.





                        Liquidity and Capital Resources



General


We have incurred negative cash flow from operations since our inception in 1998. As of December 31, 2021, we had cash of $114,000 and a stockholders' deficit of $4,173,000. Our operating cash flow in 2021 was funded primarily through cash reserves, the exercise of stock purchase warrants and options for cash, and the issuance of convertible notes for cash.

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, the Company had a net loss of $1,420,000 and used cash in operations of $722,000 for the year ended December 31, 2021. In addition, as of December 31, 2021, notes payable with an aggregate balance of $1,333,000 and certain obligation to a former officer are past due. These factors raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. Our ability to continue as a going concern is dependent upon our ability to raise additional funds and implement our business plan. The consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.





Summary


At December 31, 2021, the Company had cash on hand in the amount of $114,000. Management estimates that the current funds on hand will be sufficient to continue operations through September 2022. Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technology; costs to manufacture and ship the products; costs to maintain an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation certain payments to a former officer, during the remainder of 2021 and beyond. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stock holders, in case of equity financing.





                            Contractual Obligations


The Company's contractual commitments for future periods, including minimum guaranteed compensation payments and other agreements as described in the following table and associated footnotes:





Year ending        License           Compensation         Total
December 31,    Agreements (1)        Agreements       Obligations
    2022       $        187,500     $      197,000     $    384,500
    2023                187,500                  -          187,500
    2024                187,500                  -          187,500
    2025                187,500                  -          187,500
    2026                187,500                             187,500
       Total   $        937,500     $      197,000     $  1,134,500


___________________

    (1) Consists of license maintenance fees to Temple University in the amount of
        $187,500 paid annually through the life of the underlying patents or until
        otherwise terminated by either party. For details of the Temple Licensing
        Agreements, see Note 6 of the Financial Statements, attached hereto.








  25





Licensing Fees to Temple University

For details of the licensing agreements with Temple University, see Financial Statements attached hereto, Note 6.





                   Critical Accounting Policies and Estimates


Our discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, expenses, and related disclosure of contingent assets and liabilities. We evaluate, on an on-going basis, our estimates and judgments, including those related to the useful life of the assets. We base our estimates on historical experience and assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the results that we report in our consolidated financial statements. The SEC considers an entity's most critical accounting policies to be those policies that are both most important to the portrayal of a company's financial condition and results of operations and those that require management's most difficult, subjective or complex judgments, often as a result of the need to make estimates about matters that are inherently uncertain at the time of estimation. For a more detailed discussion of the accounting policies of the Company, see Note 1 of the Notes to the Consolidated Financial Statements, "Summary of Significant Accounting Policies".

We believe the following critical accounting policies, among others, require significant judgments and estimates used in the preparation of our consolidated financial statements.





Estimates


The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Certain significant estimates were made in connection with preparing our consolidated financial statements as described in Note 1 to Notes to Consolidated Financial Statements. Actual results could differ from those estimates.





Stock-Based Compensation



The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. From prior periods until December 31, 2018, the Company accounted for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505-50, Equity - Based Payments to Non-Employees. Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received or (b) the equity instruments issued. The final fair value of the share-based payment transaction is determined at the performance completion date.

In June 2018, the FASB issued ASU No. 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting ("ASU 2018-07"). The guidance was issued to simplify the accounting for share-based transactions by expanding the scope of ASU 2018-07 from only being applicable to share-based payments to employees to also include share-based payment transactions for acquiring goods and services from nonemployees. As a result, nonemployee share-based transactions will be measured by estimating the fair value of the equity instruments at the grant date, taking into consideration the probability of satisfying performance conditions. We adopted ASU 2018-07 on January 1, 2019. The adoption of the standard did not have a material impact on our financial statements for the year ended December 31, 2020 or the previously reported financial statements.









  26





The fair value of the Company's common stock options and warrants grant is estimated using the Black-Scholes Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes Option Pricing model could materially affect compensation expense recorded in future periods.

Recent Accounting Pronouncements

See Note 1 of the financial statements for discussion of recent accounting pronouncements.

© Edgar Online, source Glimpses